Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2003
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211180 Viricides, anticancer agents; side effect reduction
11/13/2003US20030211175 Binding to thaumalin protein; plant extracts; reduce glucose concentration
11/13/2003US20030211165 Anticancer agents; mixture of hydrophilic, crosslinked polymer and drugs
11/13/2003US20030211163 Combination antiviral therapy
11/13/2003US20030211162 Heating with carrier; mixtur eof fine and coarse particle sizes
11/13/2003US20030211161 Anhydrous mixture of polyalcohol and insulation gel; dysmenorrhea
11/13/2003US20030211156 Film-coated tablet for improved upper gastrointestinal tract safety
11/13/2003US20030211146 Dipping, molding capsules from starches
11/13/2003US20030211140 Lipid encapsulating hydrophobic core; drugs; anesthetic
11/13/2003US20030211134 Topical glycopyrrolate product
11/13/2003US20030211133 Mixture of methylcobalamin and vitamin b
11/13/2003US20030211113 Administering immunosuppressant
11/13/2003US20030211104 Methods of using cytokine antagonists to treat HIV infection and AIDS
11/13/2003US20030211103 Use of primate IFN-gamma binding molecules
11/13/2003US20030211101 Vascular endothelial growth factor-like protein from ORF viruses binds and activates mammalian VEGF receptor-2, and uses thereof
11/13/2003US20030211098 Pretreatment of animal with antibodies to sensitize animal; controlling dosage
11/13/2003US20030211097 Epidermal growth factor; antitumor, anticancer agents
11/13/2003US20030211077 Stimulanting hematopoiesis
11/13/2003US20030211076 Compositions and methods for treatment of proliferative disorders
11/13/2003US20030211040 Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
11/13/2003CA2749172A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum
11/13/2003CA2485216A1 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders
11/13/2003CA2485098A1 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003CA2485086A1 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
11/13/2003CA2484797A1 Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
11/13/2003CA2484621A1 Carvedilol formulations
11/13/2003CA2484600A1 Therapeutic use of selective pde10 inhibitors
11/13/2003CA2484599A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003CA2484425A1 Fusions of cytokines and tumor targeting proteins
11/13/2003CA2484329A1 Warming and nonirritating anhydrous lubricant compositions
11/13/2003CA2484318A1 Warming and nonirritating lubricant antifungal gel compositions
11/13/2003CA2484312A1 Catechin multimers as therapeutic drug delivery agents
11/13/2003CA2484303A1 Salt solution for colon cleansing
11/13/2003CA2484024A1 Surgical material comprising water soluble glass fibres
11/13/2003CA2483996A1 Promoters exhibiting endothelial cell specificity and methods of using same
11/13/2003CA2483927A1 Treatment of diabetes and diabetic complications with nhe-1 inhibitors
11/13/2003CA2483917A1 Formulations limiting spread of pulmonary infections
11/13/2003CA2483912A1 Alcam and alcam modulators
11/13/2003CA2483785A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
11/13/2003CA2483778A1 Biomatrix structural containment and fixation systems and methods of use thereof
11/13/2003CA2483660A1 Injectable chondrocyte implant
11/13/2003CA2483633A1 Composition and method for reducing post-prandial blood glucose
11/13/2003CA2483552A1 Calicheamicin derivative-carrier conjugates
11/13/2003CA2483099A1 Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor
11/13/2003CA2483001A1 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
11/13/2003CA2482789A1 Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treatglaucomatous retinopathies/optic neuropathies
11/13/2003CA2482784A1 Composition for treating cancer containing n,n-dimethylphytosphingosine
11/13/2003CA2480777A1 Methods of using cytokine antagonists to treat hiv infection and aids
11/13/2003CA2462879A1 Immunoconjugates for the treatment of tumours
11/12/2003EP1361273A2 Interleukin-3 (IL-3) multiple mutation polypeptides
11/12/2003EP1361229A2 Use of Tyrosine Kinase (PYK2) to produce antibodies
11/12/2003EP1361227A2 [5-carboxamide or 5-fluoro]-[2', 3'-unsaturated or 3'-modifield]-pyrimidine nucleosides
11/12/2003EP1360963A2 Ganglioside-KLH conjugate vaccines with QS-21
11/12/2003EP1360960A1 Use of ketoconazole and related substances in medicaments for treatment of type II diabetes
11/12/2003EP1360957A1 Vitamin/mineral complex
11/12/2003EP1360508A2 Prediction of wound healing by urinary nitrate assay
11/12/2003EP1360504A2 Method for screening compounds for activity in treating an osteoclast related bone disease
11/12/2003EP1360498A2 Latent human tuberculosis model, diagnostic antigens, and methods of use
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
11/12/2003EP1360311A2 Membrane penetrating peptides and uses thereof
11/12/2003EP1360304A2 Enzymes
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
11/12/2003EP1360204A2 Test system for the development of therapeutic agents, in particular active compounds for the treatment of osteoporosis
11/12/2003EP1360203A1 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions
11/12/2003EP1360199A2 Treatment involving dkk-1 or antagonists thereof
11/12/2003EP1360174A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1360172A1 Ppar agonists
11/12/2003EP1359942A1 Targetted anti-tumor drug delivery systems
11/12/2003EP1359940A2 Combinations of statins, estrogenic agents and optionally estrogens
11/12/2003EP1359939A1 Composition and method for potentiating drugs
11/12/2003EP1359936A2 Combined use of factor vii polypeptides and factor viii polypeptides
11/12/2003EP1359935A1 Combined use of factor vii polypeptides and factor ix polypeptides
11/12/2003EP1359931A1 Prevention of diabetes by administration of gnrh antagonists
11/12/2003EP1359930A2 Novisprins: antimicrobial peptides
11/12/2003EP1359920A2 Methods and formulations for the treatment of female sexual dysfunction
11/12/2003EP1359907A2 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
11/12/2003EP1359906A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/12/2003EP1359905A2 Use of mglur5 antagonists for the treatment of pruritic conditions
11/12/2003EP1359904A2 P27 prevents cellular migration
11/12/2003EP1359897A2 Cosmetic composition and method for reducing or preventing wrinkling
11/12/2003EP1359885A1 Nos inhibitors for treatment of wrinkles
11/12/2003EP1255564B1 Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
11/12/2003EP1244438B1 Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
11/12/2003EP1214062B1 Use of nicotinic acetylcholine receptor agonists for the preparation of a medicament for the treatment of dry eye disease
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1178819B1 Glutathione reductase for therapy and prophylaxis of aids
11/12/2003EP1159005B1 Pharmaceutical combination of antiviral agents
11/12/2003EP1146895B1 Thrombopoietin compositions for increasing circulating platelets
11/12/2003EP1140937B1 Antiviral nucleoside analogues
11/12/2003EP1133308B1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
11/12/2003EP1112083B1 Use of an angiogenic factor for the treatment of microvascular angiopathies
11/12/2003EP1051187B1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
11/12/2003EP0979087B1 Analgesic combination
11/12/2003EP0970379B1 Methods to identify beta-amyloid reducing agents
11/12/2003EP0897390B1 Human tumor necrosis factor delta and epsilon
11/12/2003EP0773952B1 Interaction trap systems for detecting protein interactions
1 ... 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 ... 1151